Citadel Advisors - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$639,047
-32.7%
371,539
-23.7%
0.00%
Q2 2023$949,354
-53.3%
486,848
-33.4%
0.00%
Q1 2023$2,032,916
+16.6%
731,265
+44.7%
0.00%
Q4 2022$1,742,992
+22.7%
505,215
-8.7%
0.00%
Q3 2022$1,421,000
-11.1%
553,110
-16.2%
0.00%
Q2 2022$1,598,000
-54.2%
660,287
-22.0%
0.00%
-100.0%
Q1 2022$3,489,000
-60.5%
846,796
+23.2%
0.00%
-50.0%
Q4 2021$8,838,000
+74.4%
687,281
+46.4%
0.00%
Q3 2021$5,068,000
+474.0%
469,320
+385.3%
0.00%
Q2 2021$883,000
-81.3%
96,701
-80.7%
0.00%
-100.0%
Q1 2021$4,714,000
+811.8%
499,896
+543.0%
0.00%
Q2 2020$517,000
-11.9%
77,750
-22.9%
0.00%
Q1 2020$587,000
-31.2%
100,820
+6.0%
0.00%
Q4 2019$853,000
+9.4%
95,101
+5.2%
0.00%
Q3 2019$780,000
-52.4%
90,376
-38.6%
0.00%
-100.0%
Q2 2019$1,640,000
+69.2%
147,216
+102.2%
0.00%
Q1 2019$969,000
+407.3%
72,821
+488.6%
0.00%
Q4 2018$191,000
-79.1%
12,371
-80.8%
0.00%
Q3 2018$916,00064,3060.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders